Aprea Therapeutics, Inc. (APRE)

Cash Conversion Ratio

0.97×

Quarterly · Period ending:

APRE logo

APRE Cash Conversion Ratio

Latest reported0.97×
APRE Quarterly Cash Conversion Ratio (0.99× → 0.97×)
High-resolution chart · PNG

APRE cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Cash Conversion Ratio — Quarterly
Period endingCash Conversion Ratio
0.9666×
0.9233×
1.2128×
0.6523×
1.0516×
1.4035×
1.0882×
0.7264×
0.9871×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.